Maravai Lifesciences Holdings (MRVI) Amortization of Deferred Charges (2020 - 2025)

Maravai Lifesciences Holdings' Amortization of Deferred Charges history runs 6 years deep, the most recent figure standing at $403000.0 for Q4 2025.

• In Q4 2025, Amortization of Deferred Charges fell 38.75% year-over-year to $403000.0; the TTM figure through Dec 2025 stood at $1.7 million (down 42.89% YoY), while the FY2025 annual figure was $1.7 million, down 42.89% from the prior year.
• Amortization of Deferred Charges was $403000.0 for Q4 2025 at Maravai Lifesciences Holdings, up from $399000.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $900000.0 in Q3 2021 to a low of $391000.0 in Q2 2025.
• Historically, Amortization of Deferred Charges has averaged $658000.0 across 5 years, with a median of $711000.0 in 2022.
• Biggest YoY gain for Amortization of Deferred Charges was 28.73% in 2021; the steepest drop was 96.56% in 2021.
• A 5-year view of Amortization of Deferred Charges shows it stood at $681000.0 in 2021, then declined by 3.96% to $654000.0 in 2022, then climbed by 13.61% to $743000.0 in 2023, then fell by 11.44% to $658000.0 in 2024, then plunged by 38.75% to $403000.0 in 2025.
• The last three Amortization of Deferred Charges figures came in at $403000.0 (Q4 2025), $399000.0 (Q3 2025), and $391000.0 (Q2 2025), per Business Quant data.